Mr. Taschuk has over twenty five years business experience including corporate strategy development, manufacturing, market development and finance. Prior to Radient, Mr. Taschuk was a partner and CEO of JAG Flocomponents LP.
JAG Flocomponents LP manufactured industrial valves with operations in six countries and customers in over twenty countries.
During his time with JAG Flocomponents, he oversaw the expansion of the Company into international markets.
Mr. Taschuk is also a Director of Tyhee Gold Corp. (TDC: TSX.V) and was previously a Director of the International Diabetes Federation and a Director and Chair of the Board of the Canadian Diabetes Association.
Mr. Taschuk is a Chartered Accountant and holds a Bachelor of Commerce Degree from the University of Alberta.LinkedIn
Dr. Splinter was the founding President of Radient. He is experienced in strategic planning, technical assessment and development of process technologies, business leadership, and engineering project management. Prior to founding Radient, Dr. Splinter served as Director of Chemical & Environmental Processes at BC Research, where he built and managed a team of scientists, engineers and technologists providing contract R&D services to various clients in the area of chemical and biochemical process development. Dr. Splinter is an expert in interfacial phenomena, having earned a Ph.D. in Engineering Science in 1994. He has authored or co-authored numerous scientific publications and patents and has been invited as a speaker at international science conferences. In 2003, Dr. Splinter was awarded a prestigious 5NR Science Award for Leadership in Sustainable Development for his work in advancing MAP(TM).LinkedIn
Formerly one of Canada's leading portfolio managers when he was at Front Street Capital focusing on technology and growth related investments. Prakash also spent time at Dominion Bond Rating Services, analyzing and rating structured investment products. He holds a Financial Engineering degree from York University, an MBA from the Schulich School of Business, and an undergraduate degree in Chemical Engineering.
Milo Fisher has over 15 years of experience in the biotechnology industry including production of commercial active pharmaceutical ingredients, scale-up, technology transfer and contract manufacturing. He is well versed in scheduling and overseeing all manufacturing operations under full cGMP as well as ensuring that all manufacturing staff are fully trained to operate unit equipment under GMP guidelines. Additionally, he provides solid leadership to materials management and related manufacturing support operations. He held positions with Apotex Fermentation, SYNSORB Biotech Inc. KS Avicenna and QSV Biologics Ltd. Currently, Milo is overseeing the construction and fit-up of the new ingredient manufacturing facility capable of processing 5 tons of material under ISO and GMP.LinkedIn
Tomasz has over 15 years of experience from pharmaceutical and medical devices industry.
His interdisciplinary experience spanning areas of drug design, formulation and analytical development, development and technology transfer of manufacturing processes, cross-functional project management and process risk analysis.
He began his career at Viscoplast S.A. (currently 3M Viscoplast SA) as Specialist in Technology & Development Department, carried out a preclinical drug discovery and development in Canadian Government Laboratories and prior to his position at Radient he held senior scientific position in Supratek Pharma Inc. Tomasz graduated from University of Wroclaw, with PhD in Organic Chemistry.
Mike has over ten years of senior management experience including P&L responsibility for businesses generating from $40 million to $300 million in annual revenue. Prior to Radient, Mike was Vice President and General Manager in a private equity-backed business which ultimately sold for over $750,000,000, generating a significant return for shareholders. Most recently, Mike was Managing Partner of Foundation Equity, an Edmonton-based venture capital firm. Mike holds a B.Comm from the University of Alberta.LinkedIn
Dave has more than 30 years of engineering and plants operations experience in multiple industries including biotechnology, chemicals, and explosives. He has previously the operations team a multinational company that generated $500 million in sales. In addition Dave has provided his expertise in corporate strategy, product development, business development and operation to companies is various stages of growth both domestically and internationally.Dave has BSc. in Chemical Engineering.
Marilena Radoiu is a Chartered Chemist (CChem) and a Member of the Royal Society of Chemistry (MRSC). She received a Ph.D. in Technological Organic Chemistry from the Polytechnic University of Bucharest in 1998 and an Executive MBA from the Ecole de Management Lyon (EM Lyon) in 2017.
Dr. Radoiu has extensive work experience in different international academic and industrial environments. She has worked for more than 15 years in various countries (Romania, Canada, UK and France) in the development of microwave-assisted technologies with applications to chemical synthesis, biomass extraction, plasma, food etc. Her work has included engineering and development of novel industrial and scientific standard and custom products, such as Zenith Etch and Sirius6000 (microwave plasma reactors for semiconductor gas cleaning), laboratory equipment such as MiniFlow 200 and Minilabotron 2000.
Dr. Radoiu is a fellow member of several professional associations, including the Association for Microwave Power, Education and Research in Europe (AMPERE).